Mirador Capital Partners LP Has $313,000 Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Mirador Capital Partners LP cut its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 4.0% during the 4th quarter, Holdings Channel reports. The firm owned 3,477 shares of the exchange traded fund’s stock after selling 146 shares during the quarter. Mirador Capital Partners LP’s holdings in SPDR S&P Biotech ETF were worth $313,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently modified their holdings of the company. Tidemark LLC lifted its holdings in SPDR S&P Biotech ETF by 101.5% during the 3rd quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock valued at $39,000 after purchasing an additional 199 shares during the last quarter. Quintet Private Bank Europe S.A. acquired a new position in shares of SPDR S&P Biotech ETF in the third quarter valued at $40,000. ORG Wealth Partners LLC bought a new position in shares of SPDR S&P Biotech ETF in the third quarter valued at about $44,000. Howe & Rusling Inc. acquired a new stake in SPDR S&P Biotech ETF during the third quarter worth approximately $49,000. Finally, Waldron Private Wealth LLC acquired a new stake in SPDR S&P Biotech ETF during the 3rd quarter worth approximately $54,000.

SPDR S&P Biotech ETF Price Performance

Shares of NYSEARCA XBI opened at $87.89 on Friday. The firm has a market cap of $6.70 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. The stock’s fifty day moving average price is $94.72 and its two-hundred day moving average price is $97.00. SPDR S&P Biotech ETF has a one year low of $81.14 and a one year high of $105.47.

SPDR S&P Biotech ETF Company Profile

(Free Report)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Featured Stories

• Five stocks we like better than SPDR S&P Biotech ETF
• What is diluted earnings per share (Diluted EPS)?
• Cerence AI: One-Hit Wonder or Long-Term Winner After NVIDIA Pact?
• How to Evaluate a Stock Before Buying 
• UnitedHealth Group Pulls Back Into Another Healthy Opportunity
• Why Are These Companies Considered Blue Chips?
• Micron Technology: Riding the AI Wave to Long-Term Growth

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).